m>Streptomyces</em> whole-cell biotransformations for the preparation of a number of valuable drug metabolites (<a href="#B3" class="cite-reflink bibr">3</a>).<p>CYP105D1 has previously been expressed as an active recombinant cytosolic form in <em>Escherichia coli</em> using the IPTG (isopropyl-&#x003b2;-<span class="small-caps">d</span>-thiogalactopyranoside)-inducible <em>tac</em> promoter (<a href="#B20" class="cite-reflink bibr">20</a>). Selective permeability of <em>E. coli</em> to many substrates and 